Company Filing History:
Years Active: 2020-2021
Title: Innovations of Inventor Xin Han
Introduction
Xin Han is a notable inventor based in Ann Arbor, MI (US), recognized for his contributions to the field of pharmaceuticals. He holds two patents that focus on innovative compounds aimed at treating various medical conditions, particularly cancer.
Latest Patents
His latest patents include "MDM2 protein degraders," which provide compounds represented by Formula I-A: A-L-BI-A and the pharmaceutically acceptable salts, hydrates, and solvates thereof. These compounds are designed for use in treating conditions responsive to the degradation of MDM2 protein, such as cancer. Another significant patent is for "Monofunctional intermediates for ligand-dependent target protein degradation," which details compounds represented by Formula I and their salts or solvates. These compounds serve as immunomodulators and can be utilized to prepare small-molecule drug conjugates.
Career Highlights
Xin Han is affiliated with the University of Michigan, where he conducts research and develops innovative solutions in the pharmaceutical domain. His work has significantly impacted the development of new therapeutic strategies.
Collaborations
He collaborates with esteemed colleagues, including Shaomeng Wang and Yangbing Li, who contribute to his research endeavors.
Conclusion
Xin Han's innovative work in developing compounds for cancer treatment showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer and highlight the importance of research in pharmaceuticals.